Results from a clinical trial of the experimental anti-Ebola drug TKM-130803 in Sierra Leone have shown that, at the dose given, the treatment did not improve survival in people with the disease. The Wellcome-funded trial used a new design to compared results from 14 people who received the drug with historical records of Ebola patients, […]![]()
